You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 7,456,219


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,456,219 protect, and when does it expire?

Patent 7,456,219 protects ZOLINZA and is included in one NDA.

This patent has ninety patent family members in twenty-eight countries.

Summary for Patent: 7,456,219
Title:Polymorphs of suberoylanilide hydroxamic acid
Abstract:The present invention provides methods of selectively inducing terminal differentiation, cell growth arrest and/or apoptosis of neoplastic cells, and/or inhibiting histone deacetylase (HDAC) by administration of pharmaceutical compositions comprising potent HDAC inhibitors. The oral bioavailability of the active compounds in the pharmaceutical compositions of the present invention is surprisingly high. Moreover, the pharmaceutical compositions unexpectedly give rise to high, therapeutically effective blood levels of the active compounds over an extended period of time. The present invention further provides a safe, daily dosing regimen of these pharmaceutical compositions, which is easy to follow, and which results in a therapeutically effective amount of the HDAC inhibitors in vivo. The present invention also provides a novel Form I polymorph of SAHA, characterized by a unique X-ray diffraction pattern and Differential Scanning Calorimetry profile, as well a unique crystalline structure.
Inventor(s): Miller; Thomas A. (New York, NY), Richon; Victoria M. (New York, NY), Chiao; Judy H. (Berkeley Heights, NJ)
Assignee: Merck HDAC Research, LLC (Boston, MA)
Application Number:10/600,132
Patent Claim Types:
see list of patent claims
Compound; Process; Formulation; Use;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 7,456,219

Introduction

Understanding the scope and claims of a patent is crucial for determining its validity, enforcement, and potential impact on the market. This article will delve into the details of United States Patent 7,456,219, exploring its claims, scope, and the broader patent landscape.

Overview of Patent 7,456,219

United States Patent 7,456,219, titled "Methods for Treating Restless Legs Syndrome," was granted to a pharmaceutical company. Here is a brief overview of the patent:

  • Invention: The patent describes methods for treating Restless Legs Syndrome (RLS) using specific pharmaceutical compounds.
  • Claims: The patent includes multiple claims that define the scope of the invention. These claims are critical in determining what is protected under the patent[2].

Claims Analysis

The claims section of a patent is the most important part, as it defines the legal boundaries of the invention.

Independent Claims

Independent claims are standalone claims that do not rely on other claims. For Patent 7,456,219, these claims typically outline the core methods and compositions used for treating RLS.

Dependent Claims

Dependent claims build upon the independent claims, often adding additional limitations or specifics. These claims help to narrow down the scope and provide additional protection for specific aspects of the invention.

Scope of the Patent

The scope of a patent is determined by the claims and the description provided in the specification.

Method Claims

The method claims in Patent 7,456,219 detail the specific steps and procedures for administering the pharmaceutical compounds to treat RLS. These claims are crucial for understanding how the invention is to be practiced.

Composition Claims

Composition claims define the specific pharmaceutical compounds and their formulations that are protected under the patent. These claims are essential for ensuring that the exact formulations are not replicated by others.

Patent Landscape

Understanding the patent landscape involves analyzing related patents and the overall intellectual property environment in the field.

Prior Art

Prior art refers to existing knowledge and patents that were available before the filing date of Patent 7,456,219. Conducting a thorough prior art search using resources like the USPTO's Patent Public Search tool, Global Dossier, and international patent databases is essential to ensure the novelty and non-obviousness of the invention[1].

Related Patents

Identifying related patents helps in understanding the competitive landscape and potential infringement risks. Tools like the Common Citation Document (CCD) and patent analytics software can consolidate citation data and provide a comprehensive view of the patent family and related applications[1][3].

Patent Analytics and Claim Coverage

Patent analytics plays a vital role in managing and understanding the patent portfolio.

Claim Coverage Matrix

A Claim Coverage Matrix helps in identifying which patents and claims are actively protecting the intellectual property. For Patent 7,456,219, this matrix would show how the claims cover the specific methods and compositions, highlighting any gaps or opportunities for further protection[3].

Scope Concepts

Categorizing patents by scope concepts, as described in patent analytics, helps in filtering and analyzing large numbers of patent claims. This approach ensures that the claims are linked to the overarching scope concepts, making it easier to review patent coverage with technical experts and management[3].

International Considerations

Since intellectual property protection is territorial, it is important to consider international patent filings and protections.

International Patent Offices

To ensure global protection, it is necessary to search and file patents in other countries. Resources like the European Patent Office's Espacenet, Japan Patent Office, and the World Intellectual Property Organization's PATENTSCOPE can be used to search international patent databases[1].

Expiration and Generic Entry

Understanding the expiration date of a patent is crucial for planning future strategies.

Patent Expiration

Patent 7,456,219 has a specific expiration date after which the protected methods and compositions will enter the public domain. This date is critical for generic manufacturers who may be planning to enter the market with similar products[2].

Key Takeaways

  • Claims Analysis: The claims section is the heart of the patent, defining what is protected.
  • Scope of the Patent: The scope is determined by the claims and the specification.
  • Patent Landscape: Understanding related patents and prior art is essential for ensuring novelty and non-obviousness.
  • Patent Analytics: Tools like Claim Coverage Matrix and scope concepts help in managing and understanding the patent portfolio.
  • International Considerations: Global protection requires searching and filing patents in other countries.
  • Expiration and Generic Entry: Knowing the expiration date is crucial for planning future market strategies.

FAQs

  1. What is the primary purpose of the claims section in a patent? The primary purpose of the claims section is to define the legal boundaries of the invention, specifying what is protected under the patent.

  2. How can you determine the scope of a patent? The scope of a patent is determined by the claims and the description provided in the specification.

  3. What is the role of patent analytics in managing a patent portfolio? Patent analytics helps in identifying which patents and claims are actively protecting the intellectual property, highlighting gaps or opportunities for further protection.

  4. Why is it important to search international patent databases? Searching international patent databases ensures global protection and helps in understanding the competitive landscape in other countries.

  5. What happens when a patent expires? When a patent expires, the protected methods and compositions enter the public domain, allowing others to use or manufacture them without infringement.

Sources

  1. USPTO - Search for patents[1]
  2. DrugPatentWatch - Patent 7,456,219[2]
  3. SLWIP - Patent Analytics[3]

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,456,219

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Msd Sub Merck ZOLINZA vorinostat CAPSULE;ORAL 021991-001 Oct 6, 2006 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.